| Johnny Miles, MD | |
|
1041 S Madison St, Tupelo, MS 38801-6309 | |
| (662) 844-8754 | |
| Not Available |
| Full Name | Johnny Miles |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 1041 S Madison St, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487677514 | NPI | - | NPPES |
| 0115779 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 11388 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanders Clinic For Women P.a. | 9537136254 | 9 |
News Archive
New findings from Ontario have shown that children born in Sarnia have a higher risk of developing asthma compared to neighboring cities. A research team from Lawson Health Research Institute and Western University, using provincial data from ICES, found that higher air pollution exposure in the first year of life very likely contributed to this higher risk. Their results are published today in CMAJ Open.
People with a certain type of bacteria in their guts may be more likely to develop bowel cancer.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
› Verified 6 days ago
| Entity Name | Sanders Clinic For Women P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962423046 PECOS PAC ID: 9537136254 Enrollment ID: O20040913001047 |
News Archive
New findings from Ontario have shown that children born in Sarnia have a higher risk of developing asthma compared to neighboring cities. A research team from Lawson Health Research Institute and Western University, using provincial data from ICES, found that higher air pollution exposure in the first year of life very likely contributed to this higher risk. Their results are published today in CMAJ Open.
People with a certain type of bacteria in their guts may be more likely to develop bowel cancer.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Johnny Miles, MD 1041 S Madison St, Tupelo, MS 38801-6309 Ph: (662) 844-8754 | Johnny Miles, MD 1041 S Madison St, Tupelo, MS 38801-6309 Ph: (662) 844-8754 |
News Archive
New findings from Ontario have shown that children born in Sarnia have a higher risk of developing asthma compared to neighboring cities. A research team from Lawson Health Research Institute and Western University, using provincial data from ICES, found that higher air pollution exposure in the first year of life very likely contributed to this higher risk. Their results are published today in CMAJ Open.
People with a certain type of bacteria in their guts may be more likely to develop bowel cancer.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.
› Verified 6 days ago
Clay B Hudson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1041 S Madison St, Tupelo, MS 38801 Phone: 662-844-8754 | |
Dr. Lea Elizabeth Stokes, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1041 S Madison St, Tupelo, MS 38801 Phone: 662-844-8754 | |
Wayne A Slocum, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1793 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-842-1161 Fax: 662-844-4107 | |
David E Webb, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1793 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-842-1161 Fax: 662-844-4107 | |
Chester White, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1041 S Madison St, Tupelo, MS 38801 Phone: 662-844-8754 | |
Laura L Marion, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1793 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-842-1161 Fax: 662-842-6375 | |
Ronald A Young, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1793 Cliff Gookin Blvd, Tupelo, MS 38801 Phone: 662-842-1161 Fax: 662-844-4107 |